# Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)

> **NCT00137488** · — · COMPLETED · sponsor: **AHS Cancer Control Alberta** · enrollment: 10 (actual)

## Conditions studied

- Glioma

## Interventions

- **DEVICE:** imaging and angiogenic profiles

## Key facts

- **NCT ID:** NCT00137488
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2007-12
- **Final completion:** —
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2016-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00137488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00137488, "Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT00137488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*